Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics, a leading Australian cell therapy company, has appointed Dr.

T-cell therapy is a revolutionary immunotherapy approach in which T cells are genetically modified to express a receptor that ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics made significant strides in its cell therapy programs, enrolling the first patient in its CHM CDH17 Phase 1/2 ...

Researchers at the University of Basel have developed CAR T-cells that target glioblastoma, a notoriously aggressive brain ...

The process begins with the collection of a patient’s T cells. Then these T cells are genetically modified to express ...

Legend Biotech Corporation ( (LEGN) ) has released its Q3 earnings. Here is a breakdown of the information Legend Biotech Corporation presented ...

The Filipino-born artist takes a journey through primordial mud, chimeric worlds, and suppressed psychic demons to honor ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics Ltd. has announced the issuance of nearly 70 million fully paid ordinary shares for quotation on the Australian ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

Cancer cell therapy house Chimeric Therapeutics is going to the well for a much-needed capital raising to fund its clinical programs. Read more in our health wrap. Chimeric shares have been ...

A recent meta-analysis investigating cardiovascular complications in adults undergoing chimeric antigen receptor (CAR) T-cell ...